Keith J Page

Title: Keith J Page: Innovator in Cystic Fibrosis Treatment

Introduction

Keith J Page is a notable inventor based in Hertfordshire, GB. He has made significant contributions to the field of medical treatment, particularly in addressing cystic fibrosis and chronic obstructive pulmonary disease. His innovative approach has the potential to improve the quality of life for many patients suffering from these conditions.

Latest Patents

Keith J Page holds a patent for the "Use of secretin-receptor ligands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD)." This invention is based on the discovery that the secretin receptor is expressed in the distal lung tissues of humans. In patients with cystic fibrosis, the levels of this receptor are elevated compared to normal tissue. The treatment involves administering an effective amount of an agent that triggers anion efflux in respiratory tissue via the activation of the secretin receptor. This innovative method aims to stimulate the movement of negative ions in the affected tissues, providing a new avenue for treatment.

Career Highlights

Throughout his career, Keith has been associated with Pharmagene Laboratories Limited, where he has worked on various projects aimed at advancing medical treatments. His dedication to research and development has positioned him as a key figure in the field of respiratory diseases.

Collaborations

Keith collaborates with Richard Jon Davis, contributing to the advancement of innovative solutions in medical science. Their partnership exemplifies the importance of teamwork in achieving breakthroughs in healthcare.

Conclusion

Keith J Page's work in developing treatments for cystic fibrosis and COPD showcases his commitment to improving patient outcomes through innovation. His patent reflects a significant step forward in respiratory medicine, highlighting the potential for new therapeutic approaches.